534 related articles for article (PubMed ID: 32721652)
1. Risk-Based lung cancer screening: A systematic review.
Toumazis I; Bastani M; Han SS; Plevritis SK
Lung Cancer; 2020 Sep; 147():154-186. PubMed ID: 32721652
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
3. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
6. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer mortality among construction workers: implications for early detection.
Dement JM; Ringen K; Hines S; Cranford K; Quinn P
Occup Environ Med; 2020 Apr; 77(4):207-213. PubMed ID: 31996473
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
11. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
12. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
13. [China National Lung Cancer Screening Guideline with Low-dose Computed
Tomography (2018 version)].
Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer Screening.
Choi HK; Mazzone PJ
Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
[TBL] [Abstract][Full Text] [Related]
15. Do the 2013 United States Preventive Services Task Force guidelines for lung cancer screening fail high-risk African American smokers? An institutional retrospective observational cohort study.
Thurlapati A; Velez-Martinez CS; Hirani S; Abad J; Shi R; Beedupalli K; Mansour RP
Eur J Cancer Prev; 2021 Sep; 30(5):375-381. PubMed ID: 34010237
[TBL] [Abstract][Full Text] [Related]
16. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
17. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
[TBL] [Abstract][Full Text] [Related]
18. Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.
Vachani A; Caruso C
Curr Opin Pulm Med; 2023 Jul; 29(4):232-238. PubMed ID: 37191171
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG
Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
